Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Boehringer Ingelheim RCV GmbH & Co. KG
Sponsor

Boehringer Ingelheim RCV GmbH & Co. KG

Austria Dr.-Boehringer-Gasse 5-11, Meidling, 1120 Vienna, Austria

About the sponsor

Research activity includes idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, and systemic sclerosis with lung involvement, alongside bronchiectasis. The portfolio also extends to long-term management of fibrotic lung conditions and related respiratory impairment.

  • Idiopathic pulmonary fibrosis
  • Progressive pulmonary fibrosis
  • Systemic sclerosis
  • Bronchiectasis

Key interest is centered on respiratory function, disease progression, and chronic pulmonary symptom burden.

About Specializations

Boehringer Ingelheim RCV GmbH & Co. KG runs clinical trials in conditions such as Obesity, Portal hypertension, Systemic scleroderma, Type 2 diabetes mellitus, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

12 clinical trials

Obesity

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim Espana S.A.

Systemic scleroderma

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Bi 685509
  • Sponsor:Boehringer Ingelheim Espana S.A.

Type 2 diabetes mellitus+1

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim Espana S.A.

Obesity

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH

Idiopathic pulmonary fibrosis

Not recruiting
InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bi 1015550
  • Sponsor:Boehringer Ingelheim Espana S.A.

Acute myocardial infarction

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 765845
  • Sponsor:Boehringer Ingelheim Espana S.A.

Pancreatic carcinoma+3

Not recruiting
InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:(3S,3'S,3A's,10A's)-6-Chloro-3'-(3-Chloro-2-Fluorophenyl)-1'-(Cyclopropylmethyl)-6'-Methyl-2-Oxo-1,2,3',3A',10',10A'-Hexahydro-1'H-Spiro[Indole-3,2'-Pyrrolo[2',3':4,5]Pyrrolo[1,2-B]Indazole]-7'-Carboxylic Acid
  • Sponsor:Boehringer Ingelheim Espana S.A.

Portal hypertension

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bi 685509
  • Sponsor:Boehringer Ingelheim Espana S.A.

Netherton's syndrome

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Spesolimab
  • Sponsor:Boehringer Ingelheim Espana S.A.

Hidradenitis

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Spesolimab
  • Sponsor:Boehringer Ingelheim Espana S.A.

Portal hypertension

Not recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bi 685509
  • Sponsor:Boehringer Ingelheim Espana S.A.

Bronchiectasis

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.